Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

109 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Conditionally reprogrammed cells (CRC) methodology does not allow the in vitro expansion of patient-derived primary and metastatic lung cancer cells.
Sette G, Salvati V, Giordani I, Pilozzi E, Quacquarini D, Duranti E, De Nicola F, Pallocca M, Fanciulli M, Falchi M, Pallini R, De Maria R, Eramo A. Sette G, et al. Among authors: duranti e. Int J Cancer. 2018 Jul 1;143(1):88-99. doi: 10.1002/ijc.31260. Epub 2018 Jan 26. Int J Cancer. 2018. PMID: 29341112 Free article.
Therapeutic targeting of Chk1 in NSCLC stem cells during chemotherapy.
Bartucci M, Svensson S, Romania P, Dattilo R, Patrizii M, Signore M, Navarra S, Lotti F, Biffoni M, Pilozzi E, Duranti E, Martinelli S, Rinaldo C, Zeuner A, Maugeri-Saccà M, Eramo A, De Maria R. Bartucci M, et al. Among authors: duranti e. Cell Death Differ. 2012 May;19(5):768-78. doi: 10.1038/cdd.2011.170. Epub 2011 Nov 25. Cell Death Differ. 2012. PMID: 22117197 Free PMC article.
Tyr1068-phosphorylated epidermal growth factor receptor (EGFR) predicts cancer stem cell targeting by erlotinib in preclinical models of wild-type EGFR lung cancer.
Sette G, Salvati V, Mottolese M, Visca P, Gallo E, Fecchi K, Pilozzi E, Duranti E, Policicchio E, Tartaglia M, Milella M, De Maria R, Eramo A. Sette G, et al. Among authors: duranti e. Cell Death Dis. 2015 Aug 6;6(8):e1850. doi: 10.1038/cddis.2015.217. Cell Death Dis. 2015. PMID: 26247735 Free PMC article.
Mek inhibition results in marked antitumor activity against metastatic melanoma patient-derived melanospheres and in melanosphere-generated xenografts.
Sette G, Fecchi K, Salvati V, Lotti F, Pilozzi E, Duranti E, Biffoni M, Pagliuca A, Martinetti D, Memeo L, Milella M, De Maria R, Eramo A. Sette G, et al. Among authors: duranti e. J Exp Clin Cancer Res. 2013 Nov 16;32(1):91. doi: 10.1186/1756-9966-32-91. J Exp Clin Cancer Res. 2013. PMID: 24238212 Free PMC article.
A Case of Sinonasal Melanoma With Unusual Primary Exon 17 KIT D820G Mutation.
Pilozzi E, Bartolazzi A, Fochetti F, Duranti E, Scarpino S, Valeriani M, Moriconi P, Ruco L. Pilozzi E, et al. Among authors: duranti e. Appl Immunohistochem Mol Morphol. 2016 Nov/Dec;24(10):e94-e97. doi: 10.1097/PAI.0000000000000346. Appl Immunohistochem Mol Morphol. 2016. PMID: 27153441
Epstein-Barr virus (EBV) positive classical Hodgkin lymphoma of Iraqi children: an immunophenotypic and molecular characterization of Hodgkin/Reed-Sternberg cells.
Di Napoli A, Al-Jadiri MF, Talerico C, Duranti E, Pilozzi E, Trivedi P, Anastasiadou E, Alsaadawi AR, Al-Darraji AF, Al-Hadad SA, Testi AM, Uccini S, Ruco L. Di Napoli A, et al. Among authors: duranti e. Pediatr Blood Cancer. 2013 Dec;60(12):2068-72. doi: 10.1002/pbc.24654. Epub 2013 Sep 2. Pediatr Blood Cancer. 2013. PMID: 24000236
109 results